David Baltimore - Net Worth and Insider Trading

David Baltimore Net Worth

The estimated net worth of David Baltimore is at least $9 Million dollars as of 2024-03-28. David Baltimore is the Director of Amgen Inc and owns about 31,159 shares of Amgen Inc (AMGN) stock worth over $9 Million. Details can be seen in David Baltimore's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that David Baltimore has not made any transactions after 2017-05-31 and currently still holds the listed stock(s).

Transaction Summary of David Baltimore

To

David Baltimore Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, David Baltimore owns 3 companies in total, including Regulus Therapeutics Inc () , Immune Design Corp () , and Amgen Inc () .

Click here to see the complete history of David Baltimore’s form 4 insider trades.

Insider Ownership Summary of David Baltimore

Ticker Comapny Transaction Date Type of Owner
Regulus Therapeutics Inc 2012-10-04 director
Immune Design Corp 2019-04-02 director
Amgen Inc 2017-05-31 director

David Baltimore Latest Holdings Summary

David Baltimore currently owns a total of 1 stock. David Baltimore owns 31,159 shares of Amgen Inc (AMGN) as of May 31, 2017, with a value of $9 Million.

Latest Holdings of David Baltimore

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
AMGN Amgen Inc 2017-05-31 31,159 286.97 8,941,542

Holding Weightings of David Baltimore


David Baltimore Form 4 Trading Tracker

According to the SEC Form 4 filings, David Baltimore has made a total of 0 transactions in Amgen Inc (AMGN) over the past 5 years. The most-recent trade in Amgen Inc is the sale of 3,700 shares on May 31, 2017, which brought David Baltimore around $569,541.

Insider Trading History of David Baltimore

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

David Baltimore Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

David Baltimore Ownership Network

Ownership Network List of David Baltimore

No Data

Ownership Network Relation of David Baltimore


David Baltimore Owned Company Details

What does Regulus Therapeutics Inc do?

Who are the key executives at Regulus Therapeutics Inc?

David Baltimore is the director of Regulus Therapeutics Inc. Other key executives at Regulus Therapeutics Inc include Sr. VP & General Counsel Christopher Ray Aker , Chief Operating Officer Joseph P Hagan , and Chief Financial Officer Crispina Calsada .

Regulus Therapeutics Inc () Insider Trades Summary

Over the past 18 months, David Baltimore made no insider transaction in Regulus Therapeutics Inc (). Other recent insider transactions involving Regulus Therapeutics Inc () include a net sale of 14,580 shares made by Joseph P Hagan , a net sale of 5,468 shares made by Crispina Calsada , and a net sale of 5,468 shares made by Christopher Ray Aker .

In summary, during the past 3 months, insiders sold 25,516 shares of Regulus Therapeutics Inc () in total and bought 0 shares, with a net sale of 25,516 shares. During the past 18 months, 25,516 shares of Regulus Therapeutics Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 25,516 shares.

Regulus Therapeutics Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Regulus Therapeutics Inc Insider Transactions

No Available Data

David Baltimore Mailing Address

Above is the net worth, insider trading, and ownership report for David Baltimore. You might contact David Baltimore via mailing address: Amgen Inc., One Amgen Center Drive, Thousand Oaks Ca 91320-1799.

Discussions on David Baltimore

No discussions yet.